메뉴 건너뛰기




Volumn 24, Issue 6, 2005, Pages 431-433

Characterization and mechanisms of resistance of group B streptococcal isolates obtained at a community hospital

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

EID: 21644463570     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1335-5     Document Type: Article
Times cited : (5)

References (10)
  • 1
    • 0027124375 scopus 로고
    • Group B streptococcal disease in the United States, 1990: Report from a multistate active surveillance system
    • Zangwill KM, Schuchat A, Wenger JD (1992) Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR 41(SS-6):25-32
    • (1992) MMWR , vol.41 , Issue.SS-6 , pp. 25-32
    • Zangwill, K.M.1    Schuchat, A.2    Wenger, J.D.3
  • 2
    • 0037118991 scopus 로고    scopus 로고
    • Prevention of perinatal group B streptococcal disease. Revised guidelines
    • Centers for Disease Control and Prevention (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines. MMWR 51(RR-11):1-24
    • (2002) MMWR , vol.51 , Issue.RR-11 , pp. 1-24
  • 3
    • 0036855668 scopus 로고    scopus 로고
    • Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes
    • Aracil B, Minambres M, Oteo J, De La Rosa M, Gomez-Garces JL, Alos AJ (2002) Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes. Clin Microbiol Infect 8:745-748
    • (2002) Clin Microbiol Infect , vol.8 , pp. 745-748
    • Aracil, B.1    Minambres, M.2    Oteo, J.3    De La Rosa, M.4    Gomez-Garces, J.L.5    Alos, A.J.6
  • 4
    • 0035191957 scopus 로고    scopus 로고
    • Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada
    • de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A (2001) Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45:3504-3508
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 3504-3508
    • De Azavedo, J.C.1    McGavin, M.2    Duncan, C.3    Low, D.E.4    McGeer, A.5
  • 5
    • 0016751343 scopus 로고
    • Group B streptococcus in a general hospital
    • Anthony BF, Conception NF (1975) Group B streptococcus in a general hospital. J Infect Dis 132:561-567
    • (1975) J Infect Dis , vol.132 , pp. 561-567
    • Anthony, B.F.1    Conception, N.F.2
  • 6
    • 20244385942 scopus 로고    scopus 로고
    • Antibiotic susceptibility profile for Group B streptococci isolated from neonates, 1995-1998
    • Lin FY, Azimi PH, Weisman LE, et al (2000) Antibiotic susceptibility profile for Group B streptococci isolated from neonates, 1995-1998. CID 31:76-79
    • (2000) CID , vol.31 , pp. 76-79
    • Lin, F.Y.1    Azimi, P.H.2    Weisman, L.E.3
  • 9
    • 85036950843 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing
    • NCCLS, Wayne, PA
    • National Committee for Clinical Laboratory Standards (2000) Performance standards for antimicrobial susceptibility testing. NCCLS document M2-A7. NCCLS, Wayne, PA
    • (2000) NCCLS Document M2-A7
  • 10
    • 0032917719 scopus 로고    scopus 로고
    • A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025
    • Bozdogan B, Berrezouga L, Kuo MS, et al (1999) A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob Agents Chemother 43:925-929
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 925-929
    • Bozdogan, B.1    Berrezouga, L.2    Kuo, M.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.